Komori
Jorudan (3710) · RiskMitigatedLatest Results (2026-11-12): "Worsened"

Increase in Equity-Method Investment Losses

First written in FY2016-Q3. 14 of 30 entries say "Worsened", first in FY2016. Latest entry: 2026-11-12.

30entries
11years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseWorsenedFY2021-Q3 – FY2022MitigatedFY2025-H1 – 2026-08-132016: 220162017: 320172018: 420182019: 420192020: 220202021: 420212022: 420222023: 120232024: 120242025: 220252026: 32026
Same theme, other companies

The whole theme swung hardest in 2022: 6 of 15 companies on the "Worse" side.

3 other companies' latest entry also says "Worsened".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 25 companies compared. The sentences above are computed from all 25.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1MitigatedAnnual report

    「Equity-method investment income - ¥772 thousand」

    Equity-method investment gains and losses moved from an equity-method investment loss of ¥342 thousand in the same interim period of the previous year to equity-method investment income of ¥772 thousand in the current interim period, eliminating the burden on earnings.
  2. FY2025MitigatedAnnual report

    「Equity-method investment income - ¥1.182 million」

    In contrast to the previous fiscal year, when an equity-method investment loss was recorded, the current fiscal year recorded equity-method investment income of ¥1.182 million.
  3. FY2025-H1MitigatedAnnual report

    「Equity-method investment losses ¥1.199 million ¥342 thousand」

    Equity-method investment losses decreased from ¥1.199 million in the same interim period of the previous year to ¥342 thousand, reducing the burden on earnings.
  4. FY2024-Q2WorsenedAnnual report

    「Equity-method investment losses ¥550 thousand ¥1.199 million」

    Equity-method investment losses increased from ¥550 thousand in the same period of the previous year to ¥1.199 million, increasing the burden on earnings.
  5. FY2023-Q1RestatedAnnual report

    「Equity-method investment losses ¥285 thousand ¥276 thousand」

    Equity-method investment losses decreased from ¥285 thousand in the same quarter of the previous year to ¥276 thousand, with losses continuing.
  6. FY2022WorsenedAnnual report

    「Equity-method investment losses - ¥1.114 million」

    Equity-method investment gains and losses moved from equity-method investment income of ¥11.126 million in the previous fiscal year to an equity-method investment loss of ¥1.114 million in the current fiscal year.
  7. FY2022-Q3WorsenedAnnual report

    「Equity-method investment losses - ¥864 thousand」

    Equity-method investment gains and losses moved from equity-method investment income of ¥11.410 million in the same period of the previous year to an equity-method investment loss of ¥864 thousand in the current quarter.
  8. FY2022-Q2WorsenedAnnual report

    「Equity-method investment losses - ¥576 thousand」

    Equity-method investment gains and losses moved from equity-method investment income of ¥11.695 million in the same period of the previous year to an equity-method investment loss of ¥576 thousand in the current quarter.
  9. FY2022-Q1WorsenedAnnual report

    「Equity-method investment income ¥11.977 million - Equity-method investment losses - ¥285 thousand」

    Equity-method investment gains and losses moved from a ¥11.977 million gain in the same period of the previous year to a ¥285 thousand loss in the current quarter.
  10. FY2021WorsenedAnnual report

    「Equity-method investment income ¥21.156 million ¥11.126 million」

    Equity-method investment income decreased from ¥21.156 million in the previous fiscal year to ¥11.126 million, reducing its contribution to profit.
  11. FY2021-Q3WorsenedAnnual report

    「Equity-method investment income ¥13.451 million ¥11.410 million」

    Equity-method investment income decreased from ¥13.451 million in the same period of the previous year to ¥11.410 million, reducing its contribution to profit.
  12. FY2021-Q2MitigatedAnnual report

    「Equity-method investment income ¥9.366 million ¥11.695 million」

    Equity-method investment income increased from ¥9.366 million in the same period of the previous year to ¥11.695 million, increasing its contribution to profit.
  13. FY2021-Q1MitigatedAnnual report

    「Equity-method investment income ¥10.482 million ¥11.977 million」

    Equity-method investment income increased from ¥10.482 million in the same period of the previous year to ¥11.977 million, increasing its contribution to profit.
  14. FY2020-Q3WorsenedAnnual report

    「Equity-method investment income ¥26.130 million ¥13.451 million」

    Equity-method investment income decreased from ¥26.130 million in the same period of the previous year to ¥13.451 million, reducing its contribution to profit. However, the current quarter recorded investment income rather than an investment loss.
  15. FY2020-Q1MitigatedAnnual report

    「Ordinary profit increased substantially further from the same quarter of the previous year, due in part to higher equity-method investment income and an improvement in foreign exchange gains and losses.」

    Equity-method investment gains and losses increased from a ¥458 thousand gain in the same period of the previous year to a ¥10.482 million gain, increasing the contribution to profit.
  16. FY2019RestatedAnnual report

    「This was due to the newly recorded equity-method investment income of ¥19.670 million, compared with equity-method investment losses in non-operating expenses in the previous consolidated fiscal year.」

    The fiscal year also confirmed the improvement in equity-method investment gains and losses, from a ¥50.255 million loss in the previous fiscal year to a ¥19.670 million gain in the current fiscal year.
  17. FY2019-Q3MitigatedAnnual report

    「Although foreign exchange losses increased, ordinary profit declined only slightly from the same quarter of the previous year, due in part to a substantial improvement in equity-method investment gains and losses.」

    Equity-method investment gains and losses moved from a ¥18.939 million loss in the same period of the previous year to an investment gain of ¥26.130 million, eliminating the burden on profit.
  18. FY2019-Q2MitigatedAnnual report

    「Equity-method investment income - ¥5.670 million」

    Equity-method investment gains and losses moved from a ¥19.302 million loss in the same period of the previous year to an investment gain of ¥5.670 million in the current quarter, improving the impact on profit.
  19. FY2019-Q1MitigatedAnnual report

    「Equity-method investment income - ¥458 thousand」

    Rather than an equity-method investment loss, an investment gain of ¥458 thousand was recorded, improving the impact on earnings from the ¥257 thousand equity-method investment loss in the same period of the previous year.
  20. FY2018WorsenedAnnual report

    「This was due to the newly recorded equity-method investment loss of ¥50.255 million, compared with equity-method investment income in non-operating income in the previous consolidated fiscal year.」

    Equity-method investment gains and losses deteriorated from a ¥3.982 million gain in the previous fiscal year to a ¥50.255 million loss in the current fiscal year.
  21. FY2018-Q3WorsenedAnnual report

    「Equity-method investment losses ¥18.939 million」

    Equity-method investment losses of ¥18.939 million were recorded, compared with equity-method investment gains of ¥3.008 million in the same period of the previous year.
  22. FY2018-Q2WorsenedAnnual report

    「Equity-method investment losses ¥19.302 million」

    Equity-method investment losses increased from ¥12.009 million in the same quarter of the previous year to ¥19.302 million, increasing the burden on profit.
  23. FY2018-Q1MitigatedAnnual report

    「Equity-method investment losses ¥9 million ¥257 thousand」

    Equity-method investment losses decreased from ¥9 million in the same period of the previous year to ¥257 thousand, reducing the burden on profit.
  24. FY2017-Q3MitigatedAnnual report

    「Meanwhile, ordinary profit increased from the same quarter of the previous year, as equity-method investment gains and losses improved substantially, along with an improvement in foreign exchange gains and losses.」

    Equity-method investment gains and losses moved from a ¥49.438 million loss in the same quarter of the previous year to a ¥3.008 million gain, eliminating the burden on profit.
  25. FY2017-Q2MitigatedAnnual report

    「Ordinary profit increased due to higher dividend income, the recognition of foreign exchange gains and a decrease in equity-method investment losses, among other factors.」

    Equity-method investment losses decreased from ¥19.556 million in the same quarter of the previous year to ¥12.009 million, reducing the burden on earnings.
  26. FY2017-Q1WorsenedAnnual report

    「Loss on investments accounted for using the equity method」

    Equity-method investment losses increased from ¥3.603 million in the same quarter of the previous year to ¥9 million, increasing the burden on quarterly earnings.
  27. FY2016WorsenedAnnual report

    「Equity-method investment losses amounted to ¥62.591 million, an increase of ¥62.427 million from the previous consolidated fiscal year, due to expanded losses at some equity-method affiliates and losses at companies newly subject to the equity method.」

    Equity-method investment losses increased from ¥164 thousand in the previous year to ¥62.591 million, with the expansion of losses and losses at newly applicable companies specifically stated.
  28. FY2016-Q3First statedAnnual report

    「Ordinary profit and net income attributable to owners of the parent increased from the same quarter of the previous year, as the increase in operating profit outweighed the impact of an increase in equity-method investment losses and other factors.」

    The increase in equity-method investment losses affected profit, with the income statement reporting equity-method investment losses of ¥49.438 million for the nine-month consolidated cumulative period.
Moved together

"Growth in the route-planning business centered on services for corporate customers" moved the same way as this thread, in the same document, in 8 of its 30 moves.

887776★123456
  1. ★This thread
  2. 1Growth in the route-planning business centered on services for corporate customers8×
  3. 2Reduction in the multimedia business's loss8×
  4. 3Continuing loss from the multimedia business7×
  5. 4Revenue Growth and Widening Losses in Contract Software Development and Related Businesses7×
  6. 5Higher net profit due to improved investment securities gains and losses and corporate tax burden ratio7×
  7. 6Significant decline in cash flows from operating activities6×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Jorudan's next results are scheduled for 2026-11-12. Read the earnings preview It last moved in the Results of 2026-11-12: "Worsened".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Increase in Equity-Method Investment Losses | Jorudan Co.,Ltd. (3710) | Komori